Comparison Study of Insulin Glargine and NPH Insulin

NCT01854723 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Switching to NPH insulin
DRUG: Continuation of insulin glargine

Sponsor

Providence Health & Services